Skip to content

Comparison of Safety and Efficacy Between Pencil-Point Radiofrequency Needle and Conventional Radiofrequency Needle in Patients with Craniofacial Neuropathic Pain: A Randomized, Single-Blind, Parallel-Controlled Study

Comparison of Safety and Efficacy Between Pencil-Point Radiofrequency Needle and Conventional Radiofrequency Needle in Patients with Craniofacial Neuropathic Pain: A Randomized, Single-Blind, Parallel-Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124674
Enrollment
Unknown
Registered
2026-05-15
Start date
2026-05-15
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Craniofacial Neuropathic Pain

Interventions

Pencil-point radiofrequency needle group:The patient was placed in a prone position. After receiving intravenous analgesic drugs, a puncture was performed using a tip radiofrequency needle under the g
Conventional radiofrequency needle group:The patient was placed in the prone position. After being administered the same intravenous analgesic drugs, a puncture was performed using an ordinary radiofr

Sponsors

The Third Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 18–85 years. 2.Patients clinically diagnosed with craniofacial neuropathic pain (mainly trigeminal neuralgia, postherpetic neuralgia, pterygopalatine neuralgia, glossopharyngeal neuralgia, etc.) with a Numeric Rating Scale (NRS) score >=4. 3.Failure of previous conservative treatments, such as physical therapy, exercise therapy, or analgesic medications. 4.Subjects voluntarily sign the informed consent form and agree to complete the follow-up required by the trial protocol. 5.Receive treatment according to the protocol during the treatment period.

Exclusion criteria

Exclusion criteria: 1.Severe cardiac, cerebral, renal, or hepatic insufficiency; abnormal coagulation function 2.Hemorrhage, local or systemic infection, active pulmonary tuberculosis 3.Patients with stroke or vertigo 4.Patients with mental disorders or intellectual disabilities who cannot cooperate with treatment or follow-up 5.Patients with neuropathic pain for whom radiofrequency treatment is not appropriate 6.Allergy to steroids or contrast agents 7.Presence of contraindications to puncture, such as infection at the puncture site 8.Other conditions that the investigator considers unsuitable for participation in this trial

Design outcomes

Primary

MeasureTime frame
Whether blood is aspirated during the puncture procedure.;

Secondary

MeasureTime frame
Time from puncture initiation to completion.;Intraprocedural Vital Sign Changes;Postoperative complications: such as cheek swelling, sensory abnormalities, infection, etc.;Efficacy in treating neuropathic pain: NRS scores at 3 days, 1 month, and 3 months postoperatively.;

Countries

China

Contacts

Public ContactRong Hu

The Third Xiangya Hospital, Central South University, Changsha, Hunan Province

16902407@qq.com+86 189 7316 2969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026